FDA 483 - Mission Barns, Inc. - December 05, 2023

This document is an FDA Form 482, a Notice of Inspection, issued by the Department of Health and Human Services, Food and Drug Administration. Its primary purpose is to inform an FDA-regulated entity of an upcoming or ongoing inspection, citing the legal authority for such actions. The specific firm name and inspection dates are illegible in the provided text. The regulatory framework for this inspection is established under Section 704(a)(1) of the Federal Food, Drug, and Cosmetic Act and/or Parts F or G, Title III of the Public Health Service Act. This authority permits FDA officers to enter and inspect facilities and vehicles involved in the manufacturing, processing, packing, or holding of food, drugs, devices, tobacco products, or cosmetics. The inspection scope extends to pertinent equipment, materials, containers, labeling, and, in certain cases, records and processes, with specific limitations on financial and personnel data. Special provisions are outlined for various product types, including prescription drugs, biological products, and electronic products. This Notice of Inspection does not list specific violations or required actions, as it is a preliminary document, not an inspectional observations report (FDA Form 483). It outlines the FDA's general rights during an inspection, including obtaining samples and providing a report of conditions observed upon completion. The document also informs the regulated entity of their right to seek assistance from the U.S. Small Business Administration National Ombudsman's Office and the FDA Office of the Ombudsman for complaints or disputes regarding enforcement actions.